Pharmaceutical Executive
Pharm Exec's 2011 Emerging Leaders celebration convened Oct. 6 in New York.
Pharm Exec's 2011 Emerging Pharma Leaders program convened in New York on Oct. 6 for a gathering of some of the best minds in the industry under age 45—where we recognize 30 executives from diverse backgrounds who hope to make a difference as the industry grapples with a future that is rift by uncertainty. With our cohost Cegedim Relationship Management, the day began with a Cegedim sponsored roundtable discussion on "lean management" principles and ended with a dinner celebration honoring the winners at the rooftop restaurant 220 FIFTH.
Emerging Leaders and Pharm Exec editors mingle at the outdoor cocktail reception.
Richard Gliklich, CEO, Outcome
Cegedim's Angela Miccoli, left, with Leigh-Ann Durant of EMD Serono
EPL Jessica Monroe of Johnson & Johnson with her husband Todd
Cegedim's Angela Miccoli with Soma Gupta of Pfizer
Angela Miccoli, President of the Americas for Cegedim, along with Editor-in-Chief William Looney, presented each of the Emerging Leaders with an award and a plaque incorporating their career profiles published in the June issue of Pharm Exec. The dinner also featured a guest speaker: Dr. Richard Gliklich, Professor at the Harvard Medical School and founder of Outcome Inc., a leader in the development of patient registries and other tools to build an observational database on drugs. He noted as a key trend for the future the growing size of trial data sets, whose veracity should be accompanied by "a healthy respect for their limitations" in guiding therapy decisions that will affect millions of patients—our industry's key constituency. – Jeff Schindler, Managing Editor
Cegedim's Angela Miccoli with David Stern of EMD Serono
L to R: Jeff Schindler, Managing Editor; Dave Esola, GM, Pharma/Science group; William Looney, Editor-in-Chief; and Jay Berfas, Group Publisher, Pharm Exec
Cegedim's Angela Miccoli with Steven Blum of Forest Laboratories
Young & Partners Pharmaceutical Executive Summit 2024: Brave New World – Where Are We Heading?
October 23rd 2024Peter Marks, director, Center for Biologics Evaluation and Research, FDA, presented the keynote presentation on the future of gene therapy as part of the 20th Annual Young & Partners Pharmaceutical Executive Summit held at the Yale Club of New York.
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.
Unlocking value and cost savings in patient services with technology and talent
October 2nd 2024Traci Miller, Director, Sonexus™ Access and Patient Support, Cardinal Health, discusses the current digital trends in the patient services industry and how the optimal balance of technology and talent can transform manufacturer-sponsored patient support programs. Hear how Cardinal Health combines best-in-class program and pharmacy operations with smart digital tools to ensure product and patient success and reduce operational costs.